Country: Australia
Bahasa: Inggeris
Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)
PHENYLBUTAZONE; SODIUM SALICYLATE
ZOETIS AUSTRALIA PTY LTD
phenylbutazone(186mg/mL)+sodium salicylate(50mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
PHENYLBUTAZONE ANALGESIC Active 186.0 mg/ml; SODIUM SALICYLATE PHENOL Active 50.0 mg/ml
100mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
DOG | HORSE | HORSE FOAL | BITCH | CASTRATE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES
MUSCULOSKELETAL SYSTEM
ANALGESIC | ANTI-INFLAMMATORY AGENT | MUSCULOSKELETAL CONDITIONS | ANTIPYRETIC | ARTHRITIS | ARTHROSIS | BONE SORENESS | BRUISING | BURSITIS | COLIC | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE RELAXANT | MUSCLE SORENESS | OSTEITIS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SEDATIVE | SPASMOLYTIC | SPRAINS | STRAINS | TENDON AND LIGAMENT SPRAINS | TENDON SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE | TRAUMATIC SWELLING
Poison schedule: 4; Withholding period: WHP: Meat withholding period: not to be used in horses intended for human con sumption.; Host/pest details: DOG: [ANALGESIC, ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; HORSE FOAL: [ANALGESIC, ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ANALGESIC, ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; HORSE FOAL: [ANALGESIC, ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; For the relief of painful musculoskeletal conditions in dogs and horses.Contra indications: serious cardiac, hepatic or renal dysfunction, history of blood disorders (especially haemoglobinuria), gastro intestinal disturbances.
Registered
2023-07-01
APPROVED LABEL Info PEST Verified ACTION: Phenylbutazone is a non-steroidal anti-inflammatory and analgesic agent. Sodium salicylate is an antipyretic analgesic agent. The combination of these two drugs provides both rapid action (sodium salicylate) and prolonged effect (phenylbutazone). INDICATIONS: For the relief of painful musculoskeletal conditions of dogs and horses. Such conditions include arthritis, arthrosis, osteitis, osteoarthritis, bursitis, tendonitis, tenosynovitis, and the inflammation of soft tissues and skin. When used for the relief of febrile conditions, treatment of the underlying cause should be provided concurrently with Fort Dodge Phenylbutazone with Sodium Salicylate. DIRECTIONS FOR USE: CONTRAINDICATIONS: Serious cardiac, hepatic or renal dysfunction, history of blood disorders (especially haemoglobinuria), gastro-intestinal disturbances. ADVERSE REACTIONS: Toxic reactions to Fort Dodge Phenylbutazone with Sodium Salicylate are uncommon but may be expressed as oedema of legs, jaundice, blood dyscrasia, or gastric irritation. PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY FORT DODGE PHENYLBUTAZONE WITH SODIUM SALICYLATE Contains 186 mg/mL PHENYLBUTAZONE and 50 mg/mL SODIUM SALICYLATE 100% actual size when printed on A4. 51035_43909_leaflet_MPL_VI.pdf DOSAGE AND ADMINISTRATION: DISCARD UNUSED PORTION WITHIN 28 DAYS OF FIRST BROACHING VIAL. Administer by SLOW INTRAVENOUS INJECTION at room temperature. • Horses and foals: Initially 5 - 10 mL per 225 kg per day. Subsequent doses, depending on response, may be reduced to 2.5 - 5 mL per 225 kg daily. • Dogs: 0.5 to 2.5 mL per day. Treatment in both species should be continued for 5-6 days depending on severity of condition. MEAT WITHHOLDING PERIOD: NOT TO BE USED IN HORSES INTENDED FOR HUMAN CONSUMPTION. DISPOSAL: Dispose of empty container by wrapping with paper and putting in garbage. STORAGE: Store between 2 o C and 8 o C (Refrigerate. Do not freeze). Protect from light. Discard unused portion within 2 Baca dokumen lengkap
PRODUCT NAME: FORT DODGE PHENYLBUTAZONE WITH SODIUM SALICYLATE PAGE: 1 OF 5 THIS REVISION ISSUED: JULY, 2012 SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: 1800 814 883 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 CHEMICAL NATURE: Water solution of ingredients (see below). TRADE NAME: FORT DODGE PHENYLBUTAZONE WITH SODIUM SALICYLATE APVMA CODE: 51035 PRODUCT USE: For the relief of painful musculoskeletal conditions in horses. CREATION DATE: JULY, 2012 THIS VERSION ISSUED: JULY, 2012 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S25. Avoid contact with eyes. SUSMP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Aqueous solution. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S NOTE: DIFFERENT HAZARD ASSESSMENT CRITERIA OF SWA AND TGA MAY RESULT IN SEEMING INCONSISTENCIES BETWEEN MSDS AND LABEL. EFFECTS DESCRIBED IN THIS MSDS RELATE TO SHORT TERM EMERGENCY SITUATIONS, SUCH AS ACCIDENTS AND SPILLS WITH THE POTENTIAL FOR GROSS OVEREXPOSURE, AND TO LONG TERM INDUSTRIAL AND MANUFACTURING EXPOSURE. SEE PRODUCT LABEL FOR ASSESSMENT OF HEALTH EFFECTS OF Baca dokumen lengkap